Inconsistent Guideline Recommendations for Cardiovascular Prevention and the Debate About Zeroing in on and Zeroing LDL-C Levels With PCSK9 Inhibitors

被引：7
|
作者：
Ioannidis, John P. A. [1 ,2 ,3 ,4 ]
机构：
[1] Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Hlth Res & Policy, Biomed Data Sci, Stanford, CA 94305 USA
[3] Stanford Univ, Dept Stat, Stanford, CA 94305 USA
[4] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2017年 / 318卷 / 05期
关键词：
DISEASE; MANAGEMENT;
D O I：
10.1001/jama.2017.6765
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：419 / 420
页数：2
相关论文
共 11 条
  • [1] So low ... so far so good: neurocognitive impact of lowering LDL-C levels with PCSK9 inhibitors
    Gencer, Baris
    Mach, Francois
    EUROPEAN HEART JOURNAL, 2018, 39 (05) : 382 - 384
  • [2] PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations
    Hao, Qiukui
    Aertgeerts, Bert
    Guyatt, Gordon
    Bekkering, Geertruida E.
    Vandvik, Per Olav
    Khan, Safi U.
    Rodondi, Nicolas
    Jackson, Rod
    Reny, Jean-Luc
    Al Ansary, Lubna
    Van Driel, Mieke
    Assendelft, Willem J. J.
    Agoritsas, Thomas
    Spencer, Frederick
    Siemieniuk, Reed A. C.
    Lytvyn, Lyubov
    Heen, Anja Fog
    Zhao, Qian
    Bin Riaz, Irbaz
    Ramaekers, Dirk
    Okwen, Patrick Mba
    Zhu, Ye
    Dawson, Annabel
    Ovidiu, Mersa Caius
    Vanbrabant, Willy
    Li, Sheyu
    Delvaux, Nicolas
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 377
  • [3] PCSK9 inhibitors: Ratification of the role of LDL cholesterol in cardiovascular prevention. Towards a convergence of European and North American prevention guidelines?
    Guijarro, C.
    Camafort, M.
    REVISTA CLINICA ESPANOLA, 2020, 220 (06): : 374 - 382
  • [4] Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical Trial
    Leiter, Lawrence A.
    Teoh, Hwee
    Kallend, David
    Wright, R. Scott
    Landmesser, Ulf
    Wijngaard, Peter L. J.
    Kastelein, John J. P.
    Ray, Kausik K.
    DIABETES CARE, 2019, 42 (01) : 173 - 176
  • [5] Association between plasma PCSK9 levels and 10-year progression of carotid atherosclerosis beyond LDL-C: A cohort study
    Xie, Wuxiang
    Liu, Jing
    Wang, Wei
    Wang, Miao
    Qi, Yue
    Zhao, Fan
    Sun, Jiayi
    Liu, Jun
    Li, Yan
    Zhao, Dong
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 215 : 293 - 298
  • [6] Real-World Effectiveness of PCSK9 Inhibitors in Reducing LDL-C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring Registries
    Arca, Marcello
    Celant, Simone
    Olimpieri, Pier Paolo
    Colatrella, Antonietta
    Tomassini, Luca
    D'Erasmo, Laura
    Averna, Maurizio
    Zambon, Alberto
    Catapano, Alberico Luigi
    Russo, Pierluigi
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (21):
  • [7] Beneficial impact of epigallocatechingallate on LDL-C through PCSK9/LDLR pathway by blocking HNF1α and activating FoxO3a
    Cui, Chuan-Jue
    Jin, Jing-Lu
    Guo, Lin-Na
    Sun, Jing
    Wu, Na-Qiong
    Guo, Yuan-Lin
    Liu, Geng
    Dong, Qian
    Li, Jian-Jun
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [8] A study in high-risk, maximally pretreated patients to determine the potential use of PCSK9 inhibitors at various thresholds of total and LDL cholesterol levels
    Groves, Carl
    Shetty, Chandrashekar
    Strange, Richard C.
    Waldron, Julian
    Ramachandran, Sudarshan
    POSTGRADUATE MEDICAL JOURNAL, 2017, 93 (1098) : 205 - 208
  • [9] Cost-effectiveness of adding ezetimibe and/or PCSK9 inhibitors to high-dose statins for secondary prevention of cardiovascular disease in Chinese adults
    Xiang, Yuliang
    Gan, Lei
    Du, Heyue
    Hao, Qiukui
    Aertgeerts, Bert
    Li, Sheyu
    Hu, Ming
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2023, 39 (01)
  • [10] Guideline LDL-C Threshold Achievement in Acute Myocardial Infarction Patients: A Real-World Evidence Study Demonstrating the Impact of Treatment Intensification with PCSK9i
    Mackinnon, Erin S.
    Har, Bryan
    Champsi, Salimah
    Wani, Rajvi J.
    Geyer, Lee
    Shaw, Eileen
    Farris, Megan S.
    Anderson, Todd J.
    CARDIOLOGY AND THERAPY, 2023, 12 (02) : 327 - 338
12